Steven Gothrinet
Steven Gothrinet has been part of the Hemp Gazette in-house reporting team since 2015. Steven's broad interest in cannabis was initially fueled by the realisation of industrial hemp's versatility across multiple sectors. You can contact Steve here.
Federal Reclassification Prompts TSA Guidance Update for Medical Cannabis Travel, But Ambiguity Remains
Michigan Senate Bills Aim to Transfer Industrial Hemp Program Oversight to USDA, Reduce Grower Costs
Pew Research Center Poll Shows Widespread US Cannabis Legalisation Support
Federal Cannabis Rescheduling Hearing Set as Hemp THC Ban Looms and Market Dynamics Shift
Risks and Challenges for ASX Cannabis Stocks in Australia's Medicinal Sector
Factors Shaping the Outlook for ASX Cannabis Stocks in Australia's Medicinal Market
NSW Hemp Leaders Highlight Regulatory Overlap and Inconsistency at Senate Inquiry
ASX Cannabis Stocks: Evolving Assessment Criteria for Medicinal Cannabis Companies
GCNC and Whitney Economics Report Details Europe's Expanding Role in Global Medical Cannabis Market
DOJ Rescheduling Order: Analyzing 280E Tax Implications for Medical Cannabis Businesses

